Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Pharmaceutical Business Review
Return to: PBR Home
Top Headlines

Pharmaceutical Business Review

GSK, US HHS team up to develop drugs against antibiotic resistance and bioterrorism GlaxoSmithKline (GSK) has teamed up with Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services (HHS), to develop drugs against antibiotic resistance and bioterrorism. Contract Research & Services > Contract Research > News
Duchesnay introduces Diclegis in US market By PBR Staff Writer
Duchesnay USA has announced the availability of Diclegis, a composition of 10mg doxylamine succinate and 10mg pyridoxine hydrochloride (vitamin B6), in US pharmacies.
Drug Research > Drug Discovery & Development > News Campus Biotech buys Merck Geneva headquarters By PBR Staff Writer
The Campus Biotech Consortium has purchased Merck KGaA (MRK)'s Geneva headquarters to create a biotechnology campus.
Inward Investment > News Soligenix' ThermoVax technology receives US patent By PBR Staff Writer
Clinical stage biopharmaceutical company Soligenix has received US patent for the vaccine thermostabilization technology, ThermoVax.
Regulatory Affairs > News
FDA approves entry of R-Tech ophthalmic solution into Phase I/II trials By Aalina Taylor
The FDA has approved R-Tech Ueno's novel ophthalmic solution, developed using Novozymes Biopharma's recombinant human albumin, to enter into Phase I/II trials.
Drug Research > Drug Delivery > News Corgenix partners with Eli Lilly to develop diagnostic technology By PBR Staff Writer
Corgenix Medical has collaborated with Eli Lilly to develop diagnostic technology that supports the latter's oncology pipeline program.
Automation > Laboratory Instrumentation > News Biogen Idec seeks FDA approval for Plegridy in multiple sclerosis therapy By PBR Staff Writer
Biogen Idec is seeking FDA approval for Plegridy (Peginterferon Beta-1a) as multiple sclerosis (MS) medication.
Drug Research > Drug Delivery > News

Latest News and Insight by Sector

Production & Manufacturing

US Organic Group develops over-the-counter organic anti-itch ointment
22 May 2013 | By PBR Staff Writer
US Organic Group has developed an over-the-counter organic anti-itch ointment, Anti Itchbalm, for itchy skin.
Production & Manufacturing > OTC > News
Avion unveils Prenate Chewable prenatal vitamin
22 May 2013 | By PBR Staff Writer
Avion Pharmaceuticals has unveiled a chewable, chocolate-flavored version of the Prenate prenatal vitamin family, Prenate Chewable.
Production & Manufacturing > OTC > News

Drug Research

Duchesnay introduces Diclegis in US market
23 May 2013 | By PBR Staff Writer
Duchesnay USA has announced the availability of Diclegis, a composition of 10mg doxylamine succinate and 10mg pyridoxine hydrochloride (vitamin B6), in US pharmacies.
Drug Research > Drug Discovery & Development > News
FDA approves entry of R-Tech ophthalmic solution into Phase I/II trials
23 May 2013 | By Aalina Taylor
The FDA has approved R-Tech Ueno's novel ophthalmic solution, developed using Novozymes Biopharma's recombinant human albumin, to enter into Phase I/II trials.
Drug Research > Drug Delivery > News

Inward Investment

Campus Biotech buys Merck Geneva headquarters
23 May 2013 | By PBR Staff Writer
The Campus Biotech Consortium has purchased Merck KGaA (MRK)'s Geneva headquarters to create a biotechnology campus.
Inward Investment > News
Bayer to acquire Steigerwald Arzneimittelwerk
17 May 2013 | By PBR Staff Writer
Bayer has signed an agreement to purchase 100% of the shares of Steigerwald Arzneimittelwerk.
Inward Investment > News

Packaging


Contract Research & Services

GSK, US HHS team up to develop drugs against antibiotic resistance and bioterrorism
23 May 2013 | By PBR Staff Writer
GlaxoSmithKline (GSK) has teamed up with Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services (HHS), to develop drugs against antibiotic resistance and bioterrorism.
Contract Research & Services > Contract Research > News
Jennerex completes enrollment in Phase 2b trial of liver cancer drug
22 May 2013 | By PBR Staff Writer
Jennerex Biotherapeutics has completed enrolling 120 patients in Phase 2b trial of Pexa-Vec (JX-594, pexastimogene devacirepvec) for the treatment of liver cancer.
Contract Research & Services > Clinical Trials > News

Automation

Corgenix partners with Eli Lilly to develop diagnostic technology
23 May 2013 | By PBR Staff Writer
Corgenix Medical has collaborated with Eli Lilly to develop diagnostic technology that supports the latter's oncology pipeline program.
Automation > Laboratory Instrumentation > News
Elsevier, Illumina collaborate to launch Genomics Data app
20 May 2013 | By PBR Staff Writer
Elsevier has collaborated with Illumina to launch Genomics Data app, a sequencing and array-based solutions provider for genetics research.
Automation > IT & Software > News

Regulatory Affairs

Soligenix' ThermoVax technology receives US patent
23 May 2013 | By PBR Staff Writer
Clinical stage biopharmaceutical company Soligenix has received US patent for the vaccine thermostabilization technology, ThermoVax.
Regulatory Affairs > News
Acorda obtains additional US patent for ampyra
21 May 2013 | By PBR Staff Writer
Acorda Therapeutics has obtained additional US patent for ampyra covering a range of dosage strengths.
Regulatory Affairs > News

Buy the latest industry research online today!
African Pharmaceutical Directory 2013 01 February 2013 API research into pharmaceutical companies and corporations Reports Buy online from $200


Data-Label.co.uk DataLabel have been supplying
the medical industry with labels
for over 10 years